img

Global Preventive Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Preventive Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Preventive vaccines are targeted at healthy populations and are available to susceptible populations.It refers to the preventive vaccination of the patient before the infection of the pathogen or in the body without the disease.
Preventive Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Preventive Vaccines market is projected to reach US$ 98050 million in 2034, increasing from US$ 54560 million in 2022, with the CAGR of 8.6% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Preventive Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Preventive Vaccines key manufacturers include Sanofi, AstraZeneca, CSL Ltd, Abbott, GlaxoSmithKline and Serum Institute of India, etc. Sanofi, AstraZeneca, CSL Ltd are top 3 players and held % sales share in total in 2022.
Preventive Vaccines can be divided into Intramuscular Injection, Nasal Spray and Intradermal Shot,, etc. Intramuscular Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Preventive Vaccines is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Preventive Vaccines industry development. In 2022, global % sales of Preventive Vaccines went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Preventive Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
AstraZeneca
CSL Ltd
Abbott
GlaxoSmithKline
Serum Institute of India
Segment by Type
Intramuscular Injection
Nasal Spray
Intradermal Shot

Segment by Application


Hospital
Clinic
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Preventive Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Preventive Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Preventive Vaccines industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Preventive Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Preventive Vaccines introduction, etc. Preventive Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Preventive Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Preventive Vaccines Market Overview
1.1 Preventive Vaccines Product Overview
1.2 Preventive Vaccines Market Segment by Type
1.2.1 Intramuscular Injection
1.2.2 Nasal Spray
1.2.3 Intradermal Shot
1.3 Global Preventive Vaccines Market Size by Type
1.3.1 Global Preventive Vaccines Market Size Overview by Type (2024-2034)
1.3.2 Global Preventive Vaccines Historic Market Size Review by Type (2024-2024)
1.3.3 Global Preventive Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Preventive Vaccines Sales Breakdown by Type (2024-2024)
1.4.2 Europe Preventive Vaccines Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Preventive Vaccines Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Preventive Vaccines Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Preventive Vaccines Sales Breakdown by Type (2024-2024)
2 Global Preventive Vaccines Market Competition by Company
2.1 Global Top Players by Preventive Vaccines Sales (2024-2024)
2.2 Global Top Players by Preventive Vaccines Revenue (2024-2024)
2.3 Global Top Players by Preventive Vaccines Price (2024-2024)
2.4 Global Top Manufacturers Preventive Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Preventive Vaccines Market Competitive Situation and Trends
2.5.1 Preventive Vaccines Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Preventive Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preventive Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Preventive Vaccines Market
2.8 Key Manufacturers Preventive Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Preventive Vaccines Status and Outlook by Region
3.1 Global Preventive Vaccines Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Preventive Vaccines Historic Market Size by Region
3.2.1 Global Preventive Vaccines Sales in Volume by Region (2024-2024)
3.2.2 Global Preventive Vaccines Sales in Value by Region (2024-2024)
3.2.3 Global Preventive Vaccines Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Preventive Vaccines Forecasted Market Size by Region
3.3.1 Global Preventive Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Preventive Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Preventive Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Preventive Vaccines by Application
4.1 Preventive Vaccines Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Preventive Vaccines Market Size by Application
4.2.1 Global Preventive Vaccines Market Size Overview by Application (2024-2034)
4.2.2 Global Preventive Vaccines Historic Market Size Review by Application (2024-2024)
4.2.3 Global Preventive Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Preventive Vaccines Sales Breakdown by Application (2024-2024)
4.3.2 Europe Preventive Vaccines Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Preventive Vaccines Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Preventive Vaccines Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Preventive Vaccines Sales Breakdown by Application (2024-2024)
5 North America Preventive Vaccines by Country
5.1 North America Preventive Vaccines Historic Market Size by Country
5.1.1 North America Preventive Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Preventive Vaccines Sales in Volume by Country (2024-2024)
5.1.3 North America Preventive Vaccines Sales in Value by Country (2024-2024)
5.2 North America Preventive Vaccines Forecasted Market Size by Country
5.2.1 North America Preventive Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Preventive Vaccines Sales in Value by Country (2024-2034)
6 Europe Preventive Vaccines by Country
6.1 Europe Preventive Vaccines Historic Market Size by Country
6.1.1 Europe Preventive Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Preventive Vaccines Sales in Volume by Country (2024-2024)
6.1.3 Europe Preventive Vaccines Sales in Value by Country (2024-2024)
6.2 Europe Preventive Vaccines Forecasted Market Size by Country
6.2.1 Europe Preventive Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Preventive Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Preventive Vaccines by Region
7.1 Asia-Pacific Preventive Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Preventive Vaccines Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Preventive Vaccines Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Preventive Vaccines Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Preventive Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Preventive Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Preventive Vaccines Sales in Value by Region (2024-2034)
8 Latin America Preventive Vaccines by Country
8.1 Latin America Preventive Vaccines Historic Market Size by Country
8.1.1 Latin America Preventive Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Preventive Vaccines Sales in Volume by Country (2024-2024)
8.1.3 Latin America Preventive Vaccines Sales in Value by Country (2024-2024)
8.2 Latin America Preventive Vaccines Forecasted Market Size by Country
8.2.1 Latin America Preventive Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Preventive Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Preventive Vaccines by Country
9.1 Middle East and Africa Preventive Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Preventive Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Preventive Vaccines Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Preventive Vaccines Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Preventive Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Preventive Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Preventive Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Preventive Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Sanofi Preventive Vaccines Products Offered
10.1.5 Sanofi Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Preventive Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.2.4 AstraZeneca Preventive Vaccines Products Offered
10.2.5 AstraZeneca Recent Development
10.3 CSL Ltd
10.3.1 CSL Ltd Company Information
10.3.2 CSL Ltd Introduction and Business Overview
10.3.3 CSL Ltd Preventive Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.3.4 CSL Ltd Preventive Vaccines Products Offered
10.3.5 CSL Ltd Recent Development
10.4 Abbott
10.4.1 Abbott Company Information
10.4.2 Abbott Introduction and Business Overview
10.4.3 Abbott Preventive Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Abbott Preventive Vaccines Products Offered
10.4.5 Abbott Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information
10.5.2 GlaxoSmithKline Introduction and Business Overview
10.5.3 GlaxoSmithKline Preventive Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.5.4 GlaxoSmithKline Preventive Vaccines Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Serum Institute of India
10.6.1 Serum Institute of India Company Information
10.6.2 Serum Institute of India Introduction and Business Overview
10.6.3 Serum Institute of India Preventive Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Serum Institute of India Preventive Vaccines Products Offered
10.6.5 Serum Institute of India Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Preventive Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Preventive Vaccines Industrial Chain Analysis
11.4 Preventive Vaccines Market Dynamics
11.4.1 Preventive Vaccines Industry Trends
11.4.2 Preventive Vaccines Market Drivers
11.4.3 Preventive Vaccines Market Challenges
11.4.4 Preventive Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Preventive Vaccines Distributors
12.3 Preventive Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Intramuscular Injection
Table 2. Major Company of Nasal Spray
Table 3. Major Company of Intradermal Shot
Table 4. Global Preventive Vaccines Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Preventive Vaccines Sales by Type (2024-2024) & (K Doses)
Table 6. Global Preventive Vaccines Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Preventive Vaccines Sales by Type (2024-2024) & (US& Million)
Table 8. Global Preventive Vaccines Market Share in Value by Type (2024-2024)
Table 9. Global Preventive Vaccines Price by Type (2024-2024) & (USD/Doses)
Table 10. Global Preventive Vaccines Sales by Type (2024-2034) & (K Doses)
Table 11. Global Preventive Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Preventive Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Preventive Vaccines Sales Market Share in Value by Type (2024-2034)
Table 14. Global Preventive Vaccines Price by Type (2024-2034) & (USD/Doses)
Table 15. North America Preventive Vaccines Sales by Type (2024-2024) & (K Doses)
Table 16. North America Preventive Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Preventive Vaccines Sales (K Doses) by Type (2024-2024)
Table 18. Europe Preventive Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Preventive Vaccines Sales (K Doses) by Type (2024-2024)
Table 20. Asia-Pacific Preventive Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Preventive Vaccines Sales (K Doses) by Type (2024-2024)
Table 22. Latin America Preventive Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Preventive Vaccines Sales (K Doses) by Type (2024-2024)
Table 24. Middle East and Africa Preventive Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Preventive Vaccines Sales by Company (2024-2024) & (K Doses)
Table 26. Global Preventive Vaccines Sales Share by Company (2024-2024)
Table 27. Global Preventive Vaccines Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Preventive Vaccines Revenue Share by Company (2024-2024)
Table 29. Global Market Preventive Vaccines Price by Company (2024-2024) & (USD/Doses)
Table 30. Global Preventive Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Preventive Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preventive Vaccines as of 2022)
Table 33. Date of Key Manufacturers Enter into Preventive Vaccines Market
Table 34. Key Manufacturers Preventive Vaccines Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Preventive Vaccines Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Preventive Vaccines Sales by Region (2024-2024) & (K Doses)
Table 38. Global Preventive Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Preventive Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Preventive Vaccines Sales Market Share in Value by Region (2024-2024)
Table 41. Global Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2024-2024)
Table 42. Global Preventive Vaccines Sales by Region (2024-2034) & (K Doses)
Table 43. Global Preventive Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Preventive Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Preventive Vaccines Sales Market Share in Value by Region (2024-2034)
Table 46. Global Preventive Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2024-2034)
Table 47. Global Preventive Vaccines Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Preventive Vaccines Sales by Application (2024-2024) & (K Doses)
Table 49. Global Preventive Vaccines Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Preventive Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Preventive Vaccines Sales Market Share in Value by Application (2024-2024)
Table 52. Global Preventive Vaccines Price by Application (2024-2024) & (USD/Doses)
Table 53. Global Preventive Vaccines Sales by Application (2024-2034) & (K Doses)
Table 54. Global Preventive Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Preventive Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Preventive Vaccines Sales Market Share in Value by Application (2024-2034)
Table 57. Global Preventive Vaccines Price by Application (2024-2034) & (USD/Doses)
Table 58. North America Preventive Vaccines Sales by Application (2024-2024) (K Doses)
Table 59. North America Preventive Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Preventive Vaccines Sales by Application (2024-2024) (K Doses)
Table 61. Europe Preventive Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Preventive Vaccines Sales by Application (2024-2024) (K Doses)
Table 63. Asia-Pacific Preventive Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Preventive Vaccines Sales by Application (2024-2024) (K Doses)
Table 65. Latin America Preventive Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Preventive Vaccines Sales by Application (2024-2024) (K Doses)
Table 67. Middle East and Africa Preventive Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Preventive Vaccines Sales by Country (2024-2024) & (K Doses)
Table 69. North America Preventive Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Preventive Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Preventive Vaccines Sales Market Share in Value by Country (2024-2024)
Table 72. North America Preventive Vaccines Sales by Country (2024-2034) & (K Doses)
Table 73. North America Preventive Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Preventive Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Preventive Vaccines Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Preventive Vaccines Sales by Country (2024-2024) & (K Doses)
Table 77. Europe Preventive Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Preventive Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Preventive Vaccines Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Preventive Vaccines Sales by Country (2024-2034) & (K Doses)
Table 81. Europe Preventive Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Preventive Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Preventive Vaccines Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Preventive Vaccines Sales by Region (2024-2024) & (K Doses)
Table 85. Asia-Pacific Preventive Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Preventive Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Preventive Vaccines Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Preventive Vaccines Sales by Region (2024-2034) & (K Doses)
Table 89. Asia-Pacific Preventive Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Preventive Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Preventive Vaccines Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Preventive Vaccines Sales by Country (2024-2024) & (K Doses)
Table 93. Latin America Preventive Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Preventive Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Preventive Vaccines Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Preventive Vaccines Sales by Country (2024-2034) & (K Doses)
Table 97. Latin America Preventive Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Preventive Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Preventive Vaccines Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Preventive Vaccines Sales by Country (2024-2024) & (K Doses)
Table 101. Middle East and Africa Preventive Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Preventive Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Preventive Vaccines Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Preventive Vaccines Sales by Country (2024-2034) & (K Doses)
Table 105. Middle East and Africa Preventive Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Preventive Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Preventive Vaccines Sales Market Share in Value by Country (2024-2034)
Table 108. Sanofi Company Information
Table 109. Sanofi Introduction and Business Overview
Table 110. Sanofi Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2024-2024)
Table 111. Sanofi Preventive Vaccines Product
Table 112. Sanofi Recent Development
Table 113. AstraZeneca Company Information
Table 114. AstraZeneca Introduction and Business Overview
Table 115. AstraZeneca Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2024-2024)
Table 116. AstraZeneca Preventive Vaccines Product
Table 117. AstraZeneca Recent Development
Table 118. CSL Ltd Company Information
Table 119. CSL Ltd Introduction and Business Overview
Table 120. CSL Ltd Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2024-2024)
Table 121. CSL Ltd Preventive Vaccines Product
Table 122. CSL Ltd Recent Development
Table 123. Abbott Company Information
Table 124. Abbott Introduction and Business Overview
Table 125. Abbott Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2024-2024)
Table 126. Abbott Preventive Vaccines Product
Table 127. Abbott Recent Development
Table 128. GlaxoSmithKline Company Information
Table 129. GlaxoSmithKline Introduction and Business Overview
Table 130. GlaxoSmithKline Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2024-2024)
Table 131. GlaxoSmithKline Preventive Vaccines Product
Table 132. GlaxoSmithKline Recent Development
Table 133. Serum Institute of India Company Information
Table 134. Serum Institute of India Introduction and Business Overview
Table 135. Serum Institute of India Preventive Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2024-2024)
Table 136. Serum Institute of India Preventive Vaccines Product
Table 137. Serum Institute of India Recent Development
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Preventive Vaccines Market Trends
Table 141. Preventive Vaccines Market Drivers
Table 142. Preventive Vaccines Market Challenges
Table 143. Preventive Vaccines Market Restraints
Table 144. Preventive Vaccines Distributors List
Table 145. Preventive Vaccines Downstream Customers
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Preventive Vaccines Product Picture
Figure 2. Global Preventive Vaccines Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Preventive Vaccines Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Preventive Vaccines Sales Status and Outlook (2024-2034) & (K Doses)
Figure 5. Product Picture of Intramuscular Injection
Figure 6. Global Intramuscular Injection Sales YoY Growth (2024-2034) & (K Doses)
Figure 7. Product Picture of Nasal Spray
Figure 8. Global Nasal Spray Sales YoY Growth (2024-2034) & (K Doses)
Figure 9. Product Picture of Intradermal Shot
Figure 10. Global Intradermal Shot Sales YoY Growth (2024-2034) & (K Doses)
Figure 11. Global Preventive Vaccines Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Preventive Vaccines Sales Market Share by Type in 2022 & 2034
Figure 13. North America Preventive Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. North America Preventive Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Europe Preventive Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Europe Preventive Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Preventive Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Preventive Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Latin America Preventive Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Preventive Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Preventive Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Preventive Vaccines Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Preventive Vaccines Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Preventive Vaccines Revenue in 2022
Figure 25. Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2024-2034) & (K Doses)
Figure 28. Product Picture of Clinic
Figure 29. Global Clinic Sales YoY Growth (2024-2034) & (K Doses)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2024-2034) & (K Doses)
Figure 32. Global Preventive Vaccines Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Preventive Vaccines Sales Market Share by Application in 2022 & 2034
Figure 34. North America Preventive Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. North America Preventive Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Europe Preventive Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Europe Preventive Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Preventive Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Preventive Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Latin America Preventive Vaccines Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Preventive Vaccines Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Preventive Vaccines Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Preventive Vaccines Manufacturing Cost Structure
Figure 45. Preventive Vaccines Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries